National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 1,440 shares of the business’s stock in a transaction dated Wednesday, September 21st. The shares were sold at an average price of $16.01, for a total value of $23,054.40. Following the completion of the transaction, the chief executive officer now directly owns 6,467,744 shares in the company, valued at $103,548,581.44. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.

Shares of National Research Corp. (NASDAQ:NRCIB) traded up 1.6323% on Wednesday, hitting $36.1811. The stock had a trading volume of 236 shares. The firm has a 50 day moving average of $33.92 and a 200-day moving average of $35.16. National Research Corp. has a 1-year low of $31.36 and a 1-year high of $44.60. The firm has a market capitalization of $876.34 million, a price-to-earnings ratio of 44.4485 and a beta of 0.28.

National Research Corp. (NASDAQ:NRCIB) last issued its quarterly earnings data on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.18. National Research Corp. had a return on equity of 33.74% and a net margin of 18.75%. Equities analysts predict that National Research Corp. will post $0.82 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be given a dividend of $0.48 per share. The ex-dividend date is Wednesday, September 28th. This represents a $1.92 dividend on an annualized basis and a yield of 5.31%. National Research Corp.’s payout ratio is 408.52%.

A hedge fund recently bought a new stake in National Research Corp. stock. WCM Investment Management CA purchased a new position in shares of National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 46,808 shares of the company’s stock, valued at approximately $1,554,000. WCM Investment Management CA owned 0.19% of National Research Corp. as of its most recent filing with the SEC. 2.90% of the stock is owned by hedge funds and other institutional investors.

Separately, Zacks Investment Research raised National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 price objective on the stock in a research note on Friday, August 12th.

About National Research Corp.

National Research Corp. is a business services company in the Health Care Services industry.

5 Day Chart for NASDAQ:NRCIB

Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with's FREE daily email newsletter.